David Danar, MD
Life Sciences Executive,
Biotechnology and Device Consulting

David is a medical and business professional with extensive technical and communications skills developed during more than 35 years of problem-solving and broad, in-depth experience in the healthcare and finance industry. He has been advising the Catalytic Impact Foundation since 2019.

Most recently, David has been an investment deal lead and subject matter expert for Princeton Alumni Angels and an advisor to early-stage companies focusing on a range of applications, including biotechnology, genomics data analytics, healthcare crowdfunding, global online physician community-building, and Internet-based skilled-worker job-placement. David brings to the table his medical background as a doubly board-certified pathologist trained at Harvard Medical School’s Beth Israel Hospital in Boston following a clinical internship and as a scientific and business-development professional at a startup biotechnology company, Organogenesis; and his equity finance background as a biotechnology securities analyst and Vice President at Lehman Brothers.

He leverages his years of work in journalism, editing, and research as an early employee at WebMD/Medscape, with the NY Times News Service, and at the physician newspaper Medical Tribune to build on his clinical medical and scientific knowledge and bench research experience to provide in-depth and reliable core due diligence.

While developing an online community of over 200,000 authenticated US physicians at the startup company Physicians’ Online, David gained a unique understanding of physician population behavior. As the second employee and only physician at Organogenesis, he guided product development and marketing through an initial public offering. While there, he also conducted bench research and quality control, as well as clinical protocol design, and was instrumental in bringing Eli Lilly on board as a product venture partner.

David received his MD degree from Albany Medical College and his A.B., cum laude, in chemistry from Princeton University.